The Role of Mesenchymal Stem/Stromal Cells and Their Extracellular Vesicles in Rheumatoid Arthritis

Mesenchymal Stem Cells and Extracellular Vesicles in Rheumatoid Arthritis

Authors

  • Amir Abaszadeh School of Medicine , Ilam University, Ilam, Iran
  • Oveis Salehi Tehran University of Medical Sciences, Tehran, Iran
  • Ahmadreza Badali Tabriz University of Medical Sciences, Research Center for Connective Tissue Diseases
  • Dorsa Javanmardi Fars Stem Cell Research Institute, Shiraz, Fars, Iran
  • Alireza Sarlak Student Research Committee, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Azam Lotfalian Department of Biology and Anatomical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Maryam Poudineh School of Medicine, Mashhad Azad University, Mashhad, Iran

Keywords:

Rheumatoid Arthritis; Mesenchymal Stem Cell; Extracellular Vesicle; Exosome

Abstract

There is presently no cure for the chronic inflammatory disease rheumatoid arthritis (RA), which affects the joints and other organs. Mesenchymal stem/stromal cells (MSCs) are adult stem cells that are widely studied in inflammatory diseases. Several studies have shown the therapeutic effects of MSCs in preclinical and clinical RA. However, there are a few concerns regarding the use of MSCs, such as immune rejection and malignancy. Since MSCs exert their potential effects in a paracrine manner, more attention has been paid to their extracellular vesicles (MSC-EVs). In the current study, we reviewed the application of MSCs and their EVs in RA. A better understanding of the mechanisms driving MSC and MSC-EVs in RA offers insight into possible treatment options for RA.

References

Finckh A, Gilbert B, Hodkinson B, Bae S-C, Thomas R, Deane KD et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591-602.

https://doi.org/10.1038/s41584-022-00827-y

PMid:36068354

Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3-18.

https://doi.org/10.1016/j.berh.2017.08.003

PMid:29221595 PMCid:PMC5726551

Jang S, Kwon E-J, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23(2):905.

https://doi.org/10.3390/ijms23020905

PMid:35055087 PMCid:PMC8780115

Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis-immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18(7):415-29.

https://doi.org/10.1038/s41584-022-00793-5

PMid:35705856

Adugani S, Bannimath G, Sastry P. A review on biomarkers in clinical osteoporosis-Significance of hydroxyproline. Biomed Biotechnol Res J. 2021;5(3):245-.

https://doi.org/10.4103/bbrj.bbrj_91_21

McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19.

https://doi.org/10.1056/NEJMra1004965

PMid:22150039

Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15.

https://doi.org/10.1038/s41413-018-0016-9

PMid:29736302 PMCid:PMC5920070

Lopez-Santalla M, Bueren JA, Garin MI. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies. EBioMedicine. 2021;69:103427.

https://doi.org/10.1016/j.ebiom.2021.103427

PMid:34161884 PMCid:PMC8237294

Brown C, McKee C, Bakshi S, Walker K, Hakman E, Halassy S, Svinarich D, Dodds R, Govind CK, Chaudhry GR. Mesenchymal stem cells: Cell therapy and regeneration potential. Journal of tissue engineering and regenerative medicine. 2019 Sep;13(9):1738-55.

https://doi.org/10.1002/term.2914

PMid:31216380

Cosenza S, Ruiz M, Maumus M, Jorgensen C, Noël D. Pathogenic or therapeutic extracellular vesicles in rheumatic diseases: role of mesenchymal stem cell-derived vesicles. Int J Mol Sci. 2017;18(4):889.

https://doi.org/10.3390/ijms18040889

PMid:28441721 PMCid:PMC5412468

Shaik M, Shaik M, Subramanyam G, Rajasekhar G. Identification of a subpopulation of chemoresistant cancer cells with adult stem cell properties and embryonic transcription factors in oral squamous cell carcinoma. Biomedical and Biotechnology Research Journal. 2021;5(2):170-.

https://doi.org/10.4103/bbrj.bbrj_55_21

Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-9.

https://doi.org/10.1038/nature00870

PMid:12077603

Za'ror YSMA, Zulkafli Z, Al-Eitan LN, Elsalem L, Al-Husein BA, Azlan M. The Expression of BCL11A, KLF1, and ERK of Mitogen-Activated Protein Kinase Pathway on Stem Cell Factor and Erythropoietin-Treated K562 Cells. Biomed Biotechnol Res J. 2022;6(4):563-8.

https://doi.org/10.4103/bbrj.bbrj_201_22

Meirelles LdS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(11):2204-13.

https://doi.org/10.1242/jcs.02932

PMid:16684817

Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Ganjalikhani-Hakemi M. Mesenchymal stem cell-derived extracellular vesicles: a novel cell-free therapy. Immunol Invest. 2020;49(7):758-80.

https://doi.org/10.1080/08820139.2020.1712416

PMid:32009478

Azimzadeh M, Mahmoodi M, Kazemi M, Hakemi MG, Jafarinia M, Eslami A et al. The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice. Int Immunopharmacol. 2020;87:106808.

https://doi.org/10.1016/j.intimp.2020.106808

PMid:32693359

DelaRosa O, Dalemans W, Lombardo E. Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol. 2012;23(6):978-83.

https://doi.org/10.1016/j.copbio.2012.05.005

PMid:22682584

Mansoor SR, Zabihi E, Ghasemi-Kasman M. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis. Life Sci. 2019;235:116830.

https://doi.org/10.1016/j.lfs.2019.116830

PMid:31487529

Wang Y, Ma D, Wu Z, Yang B, Li R, Zhao X et al. Clinical application of mesenchymal stem cells in rheumatic diseases. Stem Cell Res Ther. 2021;12:1-8.

https://doi.org/10.1186/s13287-021-02635-9

PMid:34753496 PMCid:PMC8579678

Tang W-Y, Liu J-H, Peng C-J, Liao Y, Luo J-S, Sun X et al. Functional characteristics and application of mesenchymal stem cells in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz). 2021;69:1-15.

https://doi.org/10.1007/s00005-021-00603-y

PMid:33713197

Elgaz S, Kuçi Z, Kuçi S, Bönig H, Bader P. Clinical use of mesenchymal stromal cells in the treatment of acute graft-versus-host disease. Transfus Med Hemother. 2019;46(1):27-34.

https://doi.org/10.1159/000496809

PMid:31244579 PMCid:PMC6558336

Chakari-Khiavi F, Dolati S, Chakari-Khiavi A, Abbaszadeh H, Aghebati-Maleki L, Pourlak T et al. Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment. Life Sci. 2019;231:116564.

https://doi.org/10.1016/j.lfs.2019.116564

PMid:31202840

Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR et al. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment. Stem Cell Res Ther. 2022;13(1):371.

https://doi.org/10.1186/s13287-022-03050-4

PMid:35902981 PMCid:PMC9331055

Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12(1):1-14.

https://doi.org/10.1186/s12967-014-0260-8

PMid:25304688 PMCid:PMC4197270

Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine. 2013;44:11-9.

https://doi.org/10.1007/s12020-012-9839-0

PMid:23203002 PMCid:PMC3726927

Bharathy MS, Jeyaleela GD, Vimala JDR, Agila A, Sheela SAM. Comparison of anti-inflammatory activities of biogenic Gymnema sylvestre-and Panicum sumatrense-mediated titanium dioxide nanoparticles. Biomedical and Biotechnology Research Journal (BBRJ). 2021;5(4):405-11.

https://doi.org/10.4103/bbrj.bbrj_164_21

Agila A, Vimala JDR, Bharathy MS, Jeyaleela GD, Sheela SAM. Anti-Oxidant and anti-cancer activities of biogenic synthesized copper oxide nanoparticles. Biomedical and Biotechnology Research Journal (BBRJ). 2022;6(3):341-8.

https://doi.org/10.4103/bbrj.bbrj_136_22

Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Azimzadeh M, Mahmoodi M et al. Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis. J Cell Physiol. 2020;235(11):8779-90.

https://doi.org/10.1002/jcp.29721

PMid:32329062

Muhammad SA. Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury. Biofactors. 2019;45(6):880-91.

https://doi.org/10.1002/biof.1563

PMid:31498511

Bang OY, Kim EH. Mesenchymal stem cell-derived extracellular vesicle therapy for stroke: challenges and progress. Front Neurol. 2019;10:211.

https://doi.org/10.3389/fneur.2019.00211

PMid:30915025 PMCid:PMC6422999

Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912.

https://doi.org/10.3389/fimmu.2020.01912

PMid:32973792 PMCid:PMC7468450

Cone AS, Yuan X, Sun L, Duke LC, Vreones MP, Carrier AN et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model. Theranostics. 2021;11(17):8129.

https://doi.org/10.7150/thno.62069

PMid:34373732 PMCid:PMC8344012

Herman S, Fishel I, Offen D. Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases. Stem Cells. 2021;39(12):1589-600.

https://doi.org/10.1002/stem.3456

PMid:34520591

Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H et al. Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations. Stem Cells. 2018;36(3):434-45.

https://doi.org/10.1002/stem.2759

PMid:29239062

Casado-Díaz A, Quesada-Gómez JM, Dorado G. Extracellular vesicles derived from mesenchymal stem cells (MSC) in regenerative medicine: applications in skin wound healing. Front Bioeng Biotechnol. 2020;8:146.

https://doi.org/10.3389/fbioe.2020.00146

PMid:32195233 PMCid:PMC7062641

Sisa C, Kholia S, Naylor J, Herrera Sanchez MB, Bruno S, Deregibus MC et al. Mesenchymal stromal cell derived extracellular vesicles reduce hypoxia-ischaemia induced perinatal brain injury. Front Physiol. 2019;10:282.

https://doi.org/10.3389/fphys.2019.00282

PMid:30941062 PMCid:PMC6433879

Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851-8.

https://doi.org/10.1002/stem.2575

PMid:28294454

Milbank E, Dragano NR, González-García I, Garcia MR, Rivas-Limeres V, Perdomo L et al. Small extracellular vesicle-mediated targeting of hypothalamic AMPKα1 corrects obesity through BAT activation. Nat Metab. 2021;3(10):1415-31.

https://doi.org/10.1038/s42255-021-00467-8

PMid:34675439

Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748-59.

https://doi.org/10.1038/s41565-021-00931-2

PMid:34211166

Watanabe Y, Tsuchiya A, Terai S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol. 2021;27(1):70.

https://doi.org/10.3350/cmh.2020.0194

PMid:33317249 PMCid:PMC7820202

Liu L, Farhoodi HP, Han M, Liu G, Yu J, Nguyen L et al. Preclinical evaluation of a single intravenous infusion of hUC-MSC (BX-U001) in rheumatoid arthritis. Cell Transplant. 2020;29:0963689720965896.

https://doi.org/10.1177/0963689720965896

PMid:33054324 PMCid:PMC7784581

Shandil RK, Dhup S, Narayanan S. Evaluation of the therapeutic potential of mesenchymal stem cells (MSCs) in preclinical models of autoimmune diseases. Stem Cells Int. 2022;2022: 6379161.

https://doi.org/10.1155/2022/6379161

PMid:35935180 PMCid:PMC9352490

Yu Y, Yoon KA, Kang TW, Jeon HJ, Sim YB, Choe SH et al. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis. J Tissue Eng Regen Med. 2019;13(7):1134-42.

https://doi.org/10.1002/term.2861

PMid:30959558

Gonzalo-Gil E, Pérez-Lorenzo MJ, Galindo M, Díaz de la Guardia R, López-Millán B, Bueno C et al. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2, 3 dioxygenase. Arthritis Res Ther. 2016;18:1-9.

https://doi.org/10.1186/s13075-016-0979-0

PMid:27036118 PMCid:PMC4818397

Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D et al. Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 2015;5(1):12777.

https://doi.org/10.1038/srep12777

PMid:26259824 PMCid:PMC4531289

Vohra M, Sharma A, Bagga R, Arora SK. Human umbilical cord-derived mesenchymal stem cells induce tissue repair and regeneration in collagen-induced arthritis in rats. J Clin Transl Res. 2020;6(6):203.

Lopez-Santalla M, Mancheño-Corvo P, Menta R, Lopez-Belmonte J, DelaRosa O, Bueren JA et al. Human adipose-derived mesenchymal stem cells modulate experimental autoimmune arthritis by modifying early adaptive T cell responses. Stem Cells. 2015;33(12):3493-503.

https://doi.org/10.1002/stem.2113

PMid:26205964

Petrelli A, Van Wijk F. CD8+ T cells in human autoimmune arthritis: the unusual suspects. Nat Rev Rheumatol. 2016;12(7):421-8.

https://doi.org/10.1038/nrrheum.2016.74

PMid:27256711

Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39(1):115-24.

https://doi.org/10.1002/art.1780390116

PMid:8546720

Shin T-H, Kim H-S, Kang T-W, Lee B-C, Lee H-Y, Kim Y-J et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7(12):e2524-e.

https://doi.org/10.1038/cddis.2016.442

PMid:28005072 PMCid:PMC5260999

Lopez-Santalla M, Fernandez-Perez R, Garin MI. Mesenchymal stem/stromal cells for rheumatoid arthritis treatment: an update on clinical applications. Cells. 2020;9(8):1852.

https://doi.org/10.3390/cells9081852

PMid:32784608 PMCid:PMC7465092

Álvaro-Gracia JM, Jover JA, García-Vicuña R, Carreño L, Alonso A, Marsal S et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis. 2017;76(1):196-202.

https://doi.org/10.1136/annrheumdis-2015-208918

PMid:27269294

Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018;20(4):499-506.

https://doi.org/10.1016/j.jcyt.2017.12.009

PMid:29428486

Ghoryani M, Shariati-Sarabi Z, Tavakkol-Afshari J, Ghasemi A, Poursamimi J, Mohammadi M. Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: a successful clinical trial in Iran. Biomed Pharmacother. 2019;109:1834-40.

https://doi.org/10.1016/j.biopha.2018.11.056

PMid:30551438

Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B et al. Human umbilical cord mesenchymal stem cell therapAbaszadeh Ay for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192-202.

https://doi.org/10.1089/scd.2013.0023

PMid:23941289

Wang L, Huang S, Li S, Li M, Shi J, Bai W et al. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I/II study. Drug Des Devel Ther. 2019:4331-40.

https://doi.org/10.2147/DDDT.S225613

PMid:31908418 PMCid:PMC6930836

Park EH, Lim H-s, Lee S, Roh K, Seo K-W, Kang K-S et al. Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med. 2018;7(9):636-42.

https://doi.org/10.1002/sctm.18-0031

PMid:30112846 PMCid:PMC6127229

Tian X, Wei W, Cao Y, Ao T, Huang F, Javed R et al. Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis. J Cell Mol Med. 2022;26(3):693-708.

https://doi.org/10.1111/jcmm.17086

PMid:34953015 PMCid:PMC8817124

Chen Z, Wang H, Xia Y, Yan F, Lu Y. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472-82.

https://doi.org/10.4049/jimmunol.1800304

PMid:30224512 PMCid:PMC6176104

Xu K, Ma D, Zhang G, Gao J, Su Y, Liu S et al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes. Mol Immunol. 2021;135:36-44.

https://doi.org/10.1016/j.molimm.2021.04.001

PMid:33857817

Downloads

Published

2024-03-01

Issue

Vol. 13 (2024): 2024: In Progress

Section

Review Article

License

Copyright (c) 2024 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/